| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a2410e115a5f5e4aae557cb3a6b8fe1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-53 |
| filingDate |
2019-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6be4b7b4d27e85daf3bbf5954676f848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18fc7b4abc0025fc92071ca121e50db8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5198ee7897f8dfbf2e1744a42f84ced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_041c74adf73535b7585a5ae599b70902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b5ac5482f06be3e27f5282772558211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84ca4d070726ac4ddc6c216ba07c7c4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14f3b10ee6097ac2acd2c1426f753822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24a9eb9f8a466073f0a00c2573406e8b |
| publicationDate |
2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021147453-A1 |
| titleOfInvention |
Dimethylphosphine oxide compound |
| abstract |
Disclosed is an application of a series of dimethylphosphine oxide compounds in the preparation of an LRRK2 kinase activity inhibitor-related drug, specifically an application of the compound shown in formula (I) or a pharmaceutically acceptable salt thereof in the preparation of an LRRK2 kinase activity inhibitor-related drug. |
| priorityDate |
2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |